RBC Capital Lowers Roper Technologies Price Target to $398
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1h ago
0mins
Source: Yahoo Finance
- Price Target Adjustment: RBC Capital has lowered Roper Technologies' price target from $539 to $398, reflecting a cautious outlook on the company's future performance, particularly following disappointing second-quarter results and guidance.
- Growth Concerns: Analysts highlight that Roper's organic growth guidance for the second half is weaker than expected, leading to diminished investor confidence in the company's future growth prospects, which may affect stock holding decisions.
- Portfolio Risks: RBC points out underperformance in three business segments—Deltek, Neptune, and Procare—further exacerbating market concerns about Roper's overall performance and prompting investors to reassess their portfolios.
- Ongoing AI Threat: Analysts warn that the emerging AI threat remains an uncertain factor for Roper, expected to continue impacting business performance over the next year, thereby increasing investment risks.
Discover Tomorrow's Bullish Stocks Today
Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.
Sign up now to unlock expert insights and stay one step ahead of the market trends.
Analyst Views on ROP
Wall Street analysts forecast ROP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ROP is 558.36 USD with a low forecast of 419.00 USD and a high forecast of 650.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
15 Analyst Rating
10 Buy
2 Hold
3 Sell
Moderate Buy
Current: 360.370
Low
419.00
Averages
558.36
High
650.00
Current: 360.370
Low
419.00
Averages
558.36
High
650.00
About ROP
Roper Technologies, Inc. is a diversified technology company. It operates businesses that design and develop vertical software and technology-enabled products for a variety of defensible niche markets. The Company operates through three segments: Application Software, Network Software and Technology Enabled Products. The Application Software segment includes Aderant, Clinisys, Data Innovations, Deltek, Frontline, IntelliTrans, PowerPlan, Procare, Strata, Transact/CBORD, and Vertafore. The Network Software segment includes ConstructConnect, DAT, Foundry, iPipeline, iTradeNetwork, Loadlink, MHA, SHP, and SoftWriters. The Technology Enabled Products segment includes CIVCO Medical Solutions, FMI, Inovonics, IPA, Neptune, Northern Digital, rf IDEAS, and Verathon. Aderant is a comprehensive management software solution for law and other professional services firms. Data Innovations is a software solution that enables the enterprise management of hospitals and independent laboratories.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Roper Technologies Q4 Earnings Miss Expectations, Shares Drop 13%
- Earnings Decline: Roper Technologies reported a 12% sales increase and an 8% rise in free cash flow for Q4, but missed Wall Street expectations, resulting in a 13% drop in share price.
- Cautious Outlook: Management's guidance for only 8% revenue growth in 2026 led to a significant stock decline, with shares now down 40% from their 52-week high.
- Market Challenges: Roper's Deltek and DAT businesses are under pressure from government budget cuts and a recession in the freight market, which has hindered performance and negatively impacted stock value.
- Acquisition Potential: Despite these challenges, management anticipates having $6 billion available for M&A or stock buybacks in 2026, which could allow for strategic acquisitions of niche software companies at discounted prices, enhancing shareholder value.
Continue Reading
ROPER STOCK FALLS 12.9% FOLLOWING Q4 REVENUE DISAPPOINTMENT
- Stock Performance: Roper shares have decreased by 12.9% following a disappointing fourth-quarter earnings report.
- Earnings Report Impact: The decline in stock price is attributed to a revision of earnings expectations that did not meet market forecasts.
Continue Reading